Alvesco Side Effects
Although most people do not experience side effects with Alvesco, some people may develop problems. In clinical studies, reported side effects included headaches, irritation of the nose, sinus infection, and joint pain, among others. Serious reactions have also been known to occur. Contact your healthcare provider immediately if you develop white patches in your mouth (thrush), vomiting, or worsening of asthma symptoms.
An Introduction to Alvesco Side EffectsJust like any medicine, Alvesco® (ciclesonide inhaler) can cause side effects. However, not everyone who takes the medication will have problems. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider.
In a survey of hospitalized patients, less than 1 percent of people taking normal doses of Alvesco reported experiencing side effects.
(This article covers many, but not all, of the possible side effects with Alvesco. Your healthcare provider can discuss a more complete list with you.)
Common Side Effects of AlvescoAlvesco has been studied extensively in clinical trials. In these studies, side effects occurring in the group of people taking Alvesco were documented and compared to those that occurred in a similar group of people taking a placebo (an inhaler with no active ingredients). This way, it is possible to see what side effects occurred, how often they appeared, and how they compared to the placebo treatments.
Based on these studies, the most common bothersome (but not usually dangerous) Alvesco side effects included:
- Headaches -- in up to 11 percent of people
- Irritation of the nose and throat -- up to 10.5 percent
- Upper respiratory infection -- up to 8.7 percent
- Sinus infection or inflammation -- up to 5.5 percent
- Nasal congestion -- up to 5.5 percent
- Throat pain -- up to 4.7 percent
- Joint pain --up to 3.5 percent
- Pain in the hands or feet -- up to 3.1 percent
- Back pain -- up to 3.1 percent.